Global Sexual Dysfunction Drugs Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 104

Report ID: 3795

Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.
The sexual dysfunction oral drugs segment accounted for the majority market share during 2017 and will continue to grow during the forecast period. The increasing cases of sexual dysfunctions are driving the need for oral therapies such as 5HT1A receptor agonist. The demand for sexual dysfunction oral drugs such as ED drugs will further increase due to the rising awareness among healthcare professionals.
The demand for sexual dysfunction drugs is increasing due to the rising prevalence of chronic diseases such as prostate cancer, diabetes mellitus, and CVD. The market will continue to grow in the region in the forthcoming years due to the rise in unhealthy lifestyle habits and the increased risk of developing sexual dysfunctions among the population.
In 2018, the global Sexual Dysfunction Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Sexual Dysfunction Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sexual Dysfunction Drugs development in United States, Europe and China.

The key players covered in this study
Pfizer
GlaxoSmithKline
Merck
Eli Lilly
AbbVie
Bayer
Teva Pharmaceutical Industries
Takeda
Apricus Biosciences
Emotional Brain
Ivix LLX
Leadiant Biosciences
NexMed
S1 Biopharma
Vietstar Biomedical Research

Market segment by Type, the product can be split into
Oral Therapy
Intracavernosal Therapy
Hormonal Therapy
Transurethral Therapy

Market segment by Application, split into
Male
Female

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Sexual Dysfunction Drugs status, future forecast, growth opportunity, key market and key players.
To present the Sexual Dysfunction Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Sexual Dysfunction Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Sexual Dysfunction Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral Therapy
1.4.3 Intracavernosal Therapy
1.4.4 Hormonal Therapy
1.4.5 Transurethral Therapy
1.5 Market by Application
1.5.1 Global Sexual Dysfunction Drugs Market Share by Application (2014-2025)
1.5.2 Male
1.5.3 Female
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Sexual Dysfunction Drugs Market Size
2.2 Sexual Dysfunction Drugs Growth Trends by Regions
2.2.1 Sexual Dysfunction Drugs Market Size by Regions (2014-2025)
2.2.2 Sexual Dysfunction Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Sexual Dysfunction Drugs Market Size by Manufacturers
3.1.1 Global Sexual Dysfunction Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Sexual Dysfunction Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Sexual Dysfunction Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Sexual Dysfunction Drugs Key Players Head office and Area Served
3.3 Key Players Sexual Dysfunction Drugs Product/Solution/Service
3.4 Date of Enter into Sexual Dysfunction Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Sexual Dysfunction Drugs Market Size by Type (2014-2019)
4.2 Global Sexual Dysfunction Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Sexual Dysfunction Drugs Market Size (2014-2019)
5.2 Sexual Dysfunction Drugs Key Players in United States
5.3 United States Sexual Dysfunction Drugs Market Size by Type
5.4 United States Sexual Dysfunction Drugs Market Size by Application

6 Europe
6.1 Europe Sexual Dysfunction Drugs Market Size (2014-2019)
6.2 Sexual Dysfunction Drugs Key Players in Europe
6.3 Europe Sexual Dysfunction Drugs Market Size by Type
6.4 Europe Sexual Dysfunction Drugs Market Size by Application

7 China
7.1 China Sexual Dysfunction Drugs Market Size (2014-2019)
7.2 Sexual Dysfunction Drugs Key Players in China
7.3 China Sexual Dysfunction Drugs Market Size by Type
7.4 China Sexual Dysfunction Drugs Market Size by Application

8 Japan
8.1 Japan Sexual Dysfunction Drugs Market Size (2014-2019)
8.2 Sexual Dysfunction Drugs Key Players in Japan
8.3 Japan Sexual Dysfunction Drugs Market Size by Type
8.4 Japan Sexual Dysfunction Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Sexual Dysfunction Drugs Market Size (2014-2019)
9.2 Sexual Dysfunction Drugs Key Players in Southeast Asia
9.3 Southeast Asia Sexual Dysfunction Drugs Market Size by Type
9.4 Southeast Asia Sexual Dysfunction Drugs Market Size by Application

10 India
10.1 India Sexual Dysfunction Drugs Market Size (2014-2019)
10.2 Sexual Dysfunction Drugs Key Players in India
10.3 India Sexual Dysfunction Drugs Market Size by Type
10.4 India Sexual Dysfunction Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Sexual Dysfunction Drugs Market Size (2014-2019)
11.2 Sexual Dysfunction Drugs Key Players in Central & South America
11.3 Central & South America Sexual Dysfunction Drugs Market Size by Type
11.4 Central & South America Sexual Dysfunction Drugs Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Sexual Dysfunction Drugs Introduction
12.1.4 Pfizer Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Sexual Dysfunction Drugs Introduction
12.2.4 GlaxoSmithKline Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Sexual Dysfunction Drugs Introduction
12.3.4 Merck Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Eli Lilly
12.4.1 Eli Lilly Company Details
12.4.2 Company Description and Business Overview
12.4.3 Sexual Dysfunction Drugs Introduction
12.4.4 Eli Lilly Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.4.5 Eli Lilly Recent Development
12.5 AbbVie
12.5.1 AbbVie Company Details
12.5.2 Company Description and Business Overview
12.5.3 Sexual Dysfunction Drugs Introduction
12.5.4 AbbVie Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.5.5 AbbVie Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Sexual Dysfunction Drugs Introduction
12.6.4 Bayer Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Teva Pharmaceutical Industries
12.7.1 Teva Pharmaceutical Industries Company Details
12.7.2 Company Description and Business Overview
12.7.3 Sexual Dysfunction Drugs Introduction
12.7.4 Teva Pharmaceutical Industries Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.7.5 Teva Pharmaceutical Industries Recent Development
12.8 Takeda
12.8.1 Takeda Company Details
12.8.2 Company Description and Business Overview
12.8.3 Sexual Dysfunction Drugs Introduction
12.8.4 Takeda Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.8.5 Takeda Recent Development
12.9 Apricus Biosciences
12.9.1 Apricus Biosciences Company Details
12.9.2 Company Description and Business Overview
12.9.3 Sexual Dysfunction Drugs Introduction
12.9.4 Apricus Biosciences Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.9.5 Apricus Biosciences Recent Development
12.10 Emotional Brain
12.10.1 Emotional Brain Company Details
12.10.2 Company Description and Business Overview
12.10.3 Sexual Dysfunction Drugs Introduction
12.10.4 Emotional Brain Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.10.5 Emotional Brain Recent Development
12.11 Ivix LLX
12.12 Leadiant Biosciences
12.13 NexMed
12.14 S1 Biopharma
12.15 Vietstar Biomedical Research

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details